European Angel® Catheter Post Market Registry
This is a post-market, observational, retrospective multi-center Registry designed to gather information on the performance of the Angel® Catheter in general clinical practice.
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
The primary objective of this multicenter, prospective, single arm clinical trial is to evaluate the safety and effectiveness of the Angel® Catheter in subjects at high risk of PE, and with recognized contraindications to standard pharmacological therapy (anticoagulation).
A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism
The primary objective of this clinical trial is to obtain initial insights into the safety of the Angel® Catheter in critically ill subjects with high risk of venous thromboembolism (VTE) disease AND who are not receiving pharmacological thromboprophylaxis.
100 项与 Bio2 Medical, Inc. 相关的临床结果
0 项与 Bio2 Medical, Inc. 相关的专利（医药）
100 项与 Bio2 Medical, Inc. 相关的药物交易
100 项与 Bio2 Medical, Inc. 相关的转化医学
